Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity the accumulation of prostaglandins, and tumor promotion caused by 12-0-tetradecanoylphorbol-13-acetate

Cancer Research

Volumn 40, Issue 2, 1980, Pages 308-315

  Verma, Ajit K ^a   Ashendel, Curtis L ^a   Boutwell, R K ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLIC AMP; DEXAMETHASONE; FLUFENAMIC ACID; INDOMETACIN; NAPROXEN; ORNITHINE DECARBOXYLASE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHODIESTERASE; PROSTAGLANDIN; RADIOISOTOPE; VINBLASTINE; VINCRISTINE;

ANIMAL EXPERIMENT; CANCER INHIBITION; CARCINOGENESIS; ENZYME INDUCTION; EPIDERMIS; LEUCINE H 3; MOUSE; ORNITHINE C 14; PROSTAGLANDIN E1 H 3; PROSTAGLANDIN F1 ALPHA H 3; SKIN; THYMIDINE H 3; TOPICAL DRUG ADMINISTRATION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMAL; CARBOXY-LYASES; CYCLOOXYGENASE INHIBITORS; FEMALE; INDOMETHACIN; MICE; NEOPLASMS, EXPERIMENTAL; ORNITHINE DECARBOXYLASE; PHORBOLS; PROSTAGLANDINS; PROSTAGLANDINS E, SYNTHETIC; SKIN; SKIN NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.; TETRADECANOYLPHORBOL ACETATE; TRETINOIN;

EID: 0018854818     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Ashendel, C.L., and Boutwell, R.K. Prostaglandin E and F levels in mouse epidermis are increased by tumor-promoting phorbol esters. Biochem. Biophys. Res. Commun., 90: 623–627, 1979.
2. Boutwell, R.K. The role of the induction of ornithine decarboxylase activity in tumor promotion. In: H.H. Hiatt, J.D. Watson, and J.A. Winsten (eds.), Origins of Human Cancer, Book B, pp. 773–783. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory, 1977.
3. Brune, K., Kalin, H., Schmidt, K., and Hecker, E. Inflammatory, tumor initiating and promoting activities of polycyclic aromatic hydrocarbons and diterpene esters of polycyclic aromatic hydrocarbons and diterpene esters in mouse skin as compared with their prostaglandin releasing potency in vitro. Cancer Lett., 4: 333–342, 1978.
4. Burton, K.A. Study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J., 62:315–323, 1956.
5. Chen, K., Heller, J., and Canellakis, E.S. Studies on the regulation of ornithine decarboxylase activity by the microtubules: the effect of colchicine and vinblastine. Biochem. Biophys. Res. Commun., 68: 401–408, 1976.
6. Flower, R.J. Drugs which inhibit prostaglandin biosynthesis. Pharmacol. Rev., 26: 33–67, 1974.
7. Fürstenberger, G., Bravo, M.D., Bertsch, S., and Marks, F. The effect of indomethacin on cell proliferation induced by chemical and mechanical means in mouse epidermis in vivo. Res. Commun. Chem. Pathol. Pharmacol., 24: 533–641, 1979.
8. Fürstenberger, G., and Marks, F. Indomethacin inhibition of cell proliferation induced by the phorbolester TPA is reversed by prostaglandin E2 in mouse epidermis in vivo. Biochem. Biophys. Res. Commun., 84:1103–1111,1978.
9. Hammarström, S., Hamberg, M., Samuelsson, B., Duell, E.A., Stawiski, M., and Voorhees, J.J. Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2a in epidermis of psoriasis. Proc. Natl. Acad. Sci. U.S.A., 72: 5130–5134, 1975.
10. Hinman, J.W. Prostaglandins. Ann. Rev. Biochem., 41: 161–178, 1972.
11. Hong, S.L., Cynkin, R.P., and Levine, L, Stimulation of prostaglandin biosynthesis by vasoactive substances in methylcholanthrene-transformed mouse Balb/3T3. J. Biol. Chem., 251: 776–780, 1976.
12. Hong, S.L., Wheless, C.M., and Levine, L. Elevated prostaglandin synthetase activity in methylcholanthrene-transformed mouse Balb/3T3. Prostaglandins, 13: 271–279, 1977.
13. Jaffe, B.M. Prostaglandins and cancer—an update. Prostaglandins, 6: 453–461, 1974.
14. Kingston, W.P., and Greaves, M.W. Factors affecting prostaglandin synthesis by rat skin microsomes. Prostaglandins, 12: 51–69, 1976.
15. Levine, L. Chemical carcinogens stimulate canine kidney (MDCK) cells to produce prostaglandins. Nature (Lond.), 268: 447–448, 1977.
16. Levine, L., and Hassid, A. Effects of phorbol 12,13-diesters on prostaglandin production and phospholipase activity in canine kidney (MDCK) cells. Biochem. Biophys. Res. Commun., 79: 477–484, 1977.
17. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265–275, 1951.
18. Lupulescu, A. Enhancement of carcinogenesis by prostaglandins in male albino Swiss mice. J. Natl. Cancer Inst., 61: 97–106, 1978.
19. Marrs, J.M., and Voorhees, J.J. A method for bioassay for an epidermal chalone-like inhibitor. J. Invest. Dermatol., 56: 174–181, 1971.
20. Mufson, R.A., Astrup, E.G., Simsiman, R.C., and Boutwell, R.K. Dissociation of increases in levels of 3′:5′-cyclic AMP and 3′:5′-cyclic GMP from induction of ornithine decarboxylase by the tumor promoter 12–0—tetradecanoylphorbol-13-acetate in mouse epidermis in vivo. Proc. Natl. Acad. Sci. U.S.A., 74: 657–661, 1977.
21. Mufson, R.A., Simsiman, R.C., and Boutwell, R.K. Increased cyclic adenosine 3′:5′-monophosphate phosphodiesterase activity in the epidermis of phorbol ester-treated mouse skin and in papillomas. Cancer Res., 39: 2036–2040, 1979.
22. O'Brien, T.G. The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res., 36: 2644–2653, 1976.
23. O'Brien, T.G., Simsiman, R.C., and Boutwell, R.K. Induction of the polyamine-biosynthetic enzymes in mouse epidermis and their specificity for tumor promotion. Cancer Res., 35: 2426–2433, 1975.
24. O'Brien, T.G., Simsiman, R.C., and Boutwell, R.K. The effect of colchicine on the induction of ornithine decarboxylase by 12-O-tetradecanoyl-phorbol-13-acetate. Cancer Res., 36: 3766–3770, 1976.
25. Orczyk, G.P., and Behrman, H.R. Ovulation blocked on indomethacin—in vivo evidence for a role of prostaglandin in gonadotrophin secretion. Prostaglandins, 1: 3–13, 1972.
26. Osterman, J., and Hammond, J.M. Prostaglandin stimulation of ovarian ornithine decarboxylase in vitro. Biochem. Biophys. Res. Commun., 83: 794–799, 1978.
27. Pace-Asciak, C.R. Oxidative biotransformation of arachidonic acid. Prostaglandins. 73: 811–817, 1977.
28. Pike, J.E. The prostaglandins. J. Invest. Dermatol., 67: 650–653, 1976.
29. Rohrschneider, L.R., and Boutwell, R.K. The early stimulation of phospholipid metabolism by 12-O-tetradecanoyl-phorboM 3-acetate and its specificity for tumor promotion. Cancer Res., 33:1945–1952, 1973.
30. Russell, D.H., Byus, C.V., and Manen, C.A. Proposed model of major sequential biochemical events of a trophic response. Life Sci., 19: 1297–1306, 1976.
31. Samuelsson, B., Goldyne, M., Granstrom, E., Hamberg, M., Hammarstrom, S., and Malmsten, C. Prostaglandins and thromboxanes. Annu. Rev. Biochem., 47: 997–1029, 1978.
32. Sun, F.F., Chapman, J.P., and McGuire, J.C. Metabolism of prostaglandin endoperoxide in animal tissues. Prostaglandins, 14: 1055–1073,1977.
33. Vane, J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol., 231: 232–235, 1971.
34. Verma, A.K., and Boutwell, R.K. Vitamin A acid (retinoic acid) a potent inhibitor of 12-O-tetradecanoylphorbo-13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Res., 37: 2196–2201, 1977.
35. Verma, A.K., Froscio, M., and Murray, A.W. Croton oil- and benzo(a)pyrene-induced changes in cyclic adenosine 3′: 5′-monophosphate and cyclic guanosine 3′:5′-monophosphate phosphodiesterase activities in mouse epidermis. Cancer Res., 36: 81–87, 1976.
36. Verma, A.K., Lowe, N.J., and Boutwell, R.K. Induction of mouse epidermal ornithine decarboxylase activity and DNA synthesis by ultraviolet light. Cancer Res., 39: 1035–1040, 1979.
37. Verma, A.K., Rice, H.M., and Boutwell, R.K. Prostaglandins and skin tumor promotion: inhibition of tumor promoter-induced ornithine decarboxylase activity by inhibitors of prostaglandin synthesis. Biochem. Biophys. Res. Commun., 79: 1160–1166, 1977.
38. Verma, A.K., Shapas, B.G., Rice, H.M., and Boutwell, R.K. Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and skin tumor promotion. Cancer Res., 39: 419–425. 1979.
39. Viaje, A., Slaga, T.J., Wigler, M., and Weinstein, I.B. Effects of anti inflammatory agents on mouse skin tumor promotion, epidermal DNA synthesis, phorbol ester-induced cellular proliferation, and production of plasminogen activator. Cancer Res., 37: 1530–1536, 1977.
40. Wilkinson, D.I., and Walsh, J.T. Prostaglandin biosynthesis in the epidermis and dermis of young mouse skin and the effect of calcium and cyclic nucleotides. J. Invest. Dermatol., 68: 210–214, 1977.
41. Ziboh, V.A. Biosynthesis of prostaglandin E2 in human skin: subcellular localization and inhibition by unsaturated fatty acids and anti-inflammatory drugs. J. Lipid Res., 14: 377–384, 1973.